Alexion Pharmaceuticals INC ALEXION PHARMACEUTICALS ORD SHS | 156.43 |
Date/Time | 01/12 / 19:17 |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | 129.00 / 6000 |
Open | 156.43 |
Previous Close | 157.07 |
High | 156.43 |
Low | 156.43 |
Volume [USD] | 2,346,495.00 |
Volume [Units] | 30,004 |
Price fixings | 3 |
ISIN | US0153511094 |
Security | 0QZM |
Exchange | London International |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 156.7000 | ![]() |
2,106,122 |
Cboe US | 156.73 | ![]() |
134,123 |
IEX | 156.72 | ![]() |
77,464 |
Frankfurt | 128.1400 | ![]() |
30 |
TradeGate | 129.620 | ![]() |
22 |
Xetra | 129.94 | ![]() |
11 |
Stuttgart | 129.460 | ![]() |
1 |
Düsseldorf | 129.76 | ![]() |
0 |
Berlin | 128.32 | ![]() |
0 |
München | 128.38 | ![]() |
0 |
Vienna Globa.. | 129.78 | ![]() |
0 |
gettex | 129.700 | ![]() |
|
Lang & Schwa.. | 128.00 | ![]() |
|
London Inter.. | 156.43 | 30,004 | |
Mexico | 3,120.34 | ![]() |
640 |
News
- BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
01/15/2021 / 14:30 - GlobeNewswire - Regulatory Expert Henrietta Ukwu, M.D. Appointed Novavax Chief Regulatory and Quality Officer
01/15/2021 / 14:00 - GlobeNewswire - Salarius Pharmaceuticals Announces Dr. Daniela Santiesteban to Participate in Panel Discussion on Targeted Cancer Therapies During Virtual NobleCon17 Investor Conference
01/15/2021 / 13:30 - GlobeNewswire - InvestorBrandNetwork Announces C3 Chat Show Podcast with CNS Pharmaceuticals Inc. Chairman and CEO John Climaco
01/13/2021 / 14:30 - GlobeNewswire - Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
01/11/2021 / 16:50 - GlobeNewswire